Douglas E. Williams - Jun 4, 2025 Form 4 Insider Report for Climb Bio, Inc. (CLYM)

Role
Director
Signature
Emily Pimblett, as Attorney-in-Fact
Stock symbol
CLYM
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/5/2025, 04:11 PM
Previous filing
Apr 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WILLIAMS DOUGLAS E Director C/O CLIMB BIO, INC., 20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS Emily Pimblett, as Attorney-in-Fact 2025-06-05 0001184847

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLYM Stock Option (Right to Buy) Award $0 +40K $0.00 40K Jun 4, 2025 Common Stock 40K $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 4, 2026 or the date immediately prior to the date of the next annual meeting of stockholders, subject to the reporting person's continued service through such date.